Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search

		Submit


Tuberculosis (TB)


Section Navigation
			
			CDC Home








Program Evaluation						Print
													Updated October 30, 2023
																	Related Pages
										**Improving TB Prevention and Control Through Program Evaluation**
Public health programs can use program evaluation to improve TB prevention and control activities. Explore the following links to learn more about program evaluation resources.Program Evaluation ToolsProgram Evaluation Tools
Tools to assist programs with evaluation activities, from identifying a focus area to applying evaluation findingsProgram Evaluation SupportProgram Evaluation Support
The TB Program Evaluation Network (PEN) and CDC offer evaluation support to TB programsResources for Modeling & CostsResources for Modeling %26 Costs
Resources to project TB incidence and estimate costsProgram Evaluation Success Stories from TB Programs**DTBE Data Sources**
State and local TB programs can monitor their performance in achieving national TB program objectives and targets, track their contact investigation activities, and assess their performance in relation to other TB programs by using available data sources developed by CDC’s Division of Tuberculosis Elimination (DTBE).
The National Tuberculosis Indicators Project (NTIP) is an Internet-based performance-monitoring tool that allows TB programs to assess their progress toward achieving National TB Program Objectives and Targets.
Learn more about National TB Targets and how they are calculated.
The Aggregate Reports for Tuberculosis Program Evaluation (ARPE) collects information about TB program activities on contact investigations and targeted testing. Each year, DTBE publishes the Contact Investigations Report (ARPE Data) summarizing contact investigation and LTBI treatment data submitted to CDC by TB programs and describing program performance in meeting National TB Program Objectives and Performance Targets.
Each year, DTBE publishes a State and City Report summarizing data submitted to CDC. This report allows TB programs to compare their progress in achieving national TB objectives to the progress of other TB programs with similar TB incidence.
Beginning in 2020, CDC-funded state and city TB programs with ≥150 TB cases are required to submit targeted testing data (as outlined in the cooperative agreements). TB programs report results of their targeted testing activities to CDC by entering the data into the Aggregate Reports for Tuberculosis Program Evaluation (ARPE) form through the National Tuberculosis Indicators Project (NTIP) performance-monitoring tool. The Targeted Testing Report summarizes targeted testing data that is submitted to CDC by TB programs.**Other Data Sources for TB Programs**Reported Tuberculosis in the United States, 2022Online TB Information System (OTIS) DataCDC AtlasPlus Charts, Maps, and TablesFrequently Asked Questions About Program Evaluation
Open All Close All
When should program evaluation begin?A common misconception is that evaluation is something you do after program activities have been implemented and completed. Ideally, evaluation should be included in the planning phase and continued throughout the entire course of the program. Although eliminating TB is the long-term goal of your program, reaching that goal means evaluating your efforts and using that information to continuously improve program performance and practice. Even if you are still in the program planning process, you can evaluate who is involved and why. By conducting evaluation activities early in the program planning process, you are laying the groundwork for better strategic planning, data accuracy, and stronger collaboration with partners, and paving the way to confidently verify how your program has contributed to intended outcomes.Does evaluation need to be elaborate?Evaluations can be as different as the programs being evaluated. Program leadership and staff decide how complex an evaluation needs to be. Starting small is often a good idea, and you probably already have valuable information you can use in your evaluation.Who should be involved in the evaluation?Program evaluation often needs to include many types of partnerships and collaborations. The good news is that everyone won’t need to commit the same amount of time and energy to the process. Often a small team, one that is consistently and intensively involved and engaged in the evaluation process, can be an effective way to keep the process manageable.Does conducting an evaluation take resources away from regular program operation?Good program evaluation shows how well you are using your resources. Are the activities working? If so, wonderful! Now you know for sure. Do they need to be modified? Have you been duplicating efforts without realizing it? Are your activities ineffective? This is also great information to have so that you use your financial resources most efficiently or you can identify where to make improvements. Program evaluation not only reveals how effectively you are using your resources, it can be a way to showcase your successful activities or components to stakeholders. Don’t forget that you can start small and scale up as you are able. You already track information for funders and other stakeholders. Consider what you can do with the information you already collect during normal program operations.Does conducting an evaluation consume a lot of time?Program evaluation does not necessarily require a significant time commitment. Although effort will be needed, it will be time well spent to have conducted a thorough and useful evaluation with the time you are able to dedicate. As a result of doing an evaluation, you might also identify time savings that can be applied in other priority areas.Will the findings make our program look bad?You might find that some of what you are doing can be done better. Learning organizations — that is, organizations that learn from experience to continually improve their program practices — understand that both success and failure provide constructive feedback for building a better program. Being flexible in this way will show that your program is adaptable and committed to continuous improvement.Related LinksTB Program Evaluation Resources
Aggregate Reports for Tuberculosis Program Evaluation: Training Manual and User’s GuideThe National Tuberculosis Indicators Project (NTIP)
NTIP is a monitoring system for tracking the progress of U.S. TB control programs toward achieving the national TB program objectives.
National TB Program Objectives and Performance Targets for 2025
Background
Using the National TB Indicators Project to Select a Focus Area for Program Evaluation
The National Tuberculosis Indicators Project (NTIP)– Fact sheet
NTIP User Guide
NTIP Companion for Data ManagersUnderstanding the Cohort Review Process
Monitoring Tuberculosis Programs *MMWR* 2010; 59 (No.10); 295-298
							
					
							Last Reviewed:  March 9, 2023						Source: 	Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
					Facebook
        Twitter
        LinkedIn
        Syndicate homeTuberculosisBasic TB Factsplus iconHow TB SpreadsLatent TB Infection and TB DiseaseSigns & SymptomsTB Risk FactorsExposure to TBTB PreventionVaccinesTB & HIV CoinfectionTB and DiabetesTB TermsPersonal StoriesTesting & Diagnosisplus iconWho Should be TestedTesting for TB InfectionTesting in BCG-Vaccinated PersonsTB Screening and Testing of Health Care PersonnelTesting During PregnancyDiagnosing latent TB infection and TB diseaseTreatmentplus iconDeciding When to Treat Latent TB InfectionTreatment Regimens for Latent TB Infection (LTBI)Treatment for TB DiseaseAdverse EventsTB Treatment of Persons Living with HIVTB Treatment and PregnancyTB Treatment for ChildrenFrequently Asked QuestionsDrug-Resistant TBResearchplus iconTB Epidemiologic Studies Consortiumplus iconResearch ProjectsPublicationsTB Trials Consortiumplus iconStudy DescriptionsBackgroundBehavioral & Social Science ResearchHealth Care Settingsplus iconTB Infection Control in Health Care SettingsResources for TB Screening and Testing of Health Care Personnelplus iconFrequently Asked QuestionsTB in Specific Populationsplus iconHealth DisparitiesAsian PersonsBlack or African American PersonsHispanic or Latino PersonsChildrenPregnancyCorrectional FacilitiesPeople Experiencing HomelessnessInternational TravelersLaboratory Informationplus iconDrug Susceptibility TestingFalse-Positive Investigation ToolkitInterim Laboratory Biosafety Guidance for XDR  tuberculosis strainsModel Performance Evaluation Program (MPEP)Rapid Molecular Testing to Detect Drug-Resistant TB in the USplus iconExecutive SummaryIntroductionBackground on Tests for Molecular Detection of DRGeneral Considerations and Principles for a Molecular DR Testing ServicePossible Scenarios and Scope of Testing for a Molecular DR Testing ServiceResearch NeedsGeneral Recommendations of the Expert PanelCommunication Plan for the ReportRecommendationsReferencesPanel Members and CDC ParticipantsAppendix 1Appendix 2Appendix 3The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TBplus iconGeneral ConsiderationsGeneral Recommendations of the Expert PanelRecommendations to ACET, CDC, DTBEData & Statisticsplus iconTB Incidence in the United StatesReported TB in the US, 2022 Surveillance Reportplus iconNational DataReporting Area DataRisk FactorsDemographicsTB Treatment and Case OutcomesDrug-Resistant TBMolecular SurveillanceTuberculosis in the United States, 2022 (Slide Set)Archived Surveillance Reports and Slide Sets2021 State and City ReportArchived State and City ReportsProfessional Resources & Toolsplus iconTools for Healthcare ProvidersResources for TB Programsplus iconStrengthening Civil Surgeons’ Capacity to Improve LTBI Surveillance and Outcomes Among Status AdjustersNotice of Funding Opportunity (NOFO)Program EvaluationTB Centers of ExcellenceTB Elimination AllianceTB Genotypingplus iconConventional TB GenotypingWhole Genome SequencingTB GIMSAnalytic ToolsLatent Tuberculosis Infection ResourcesPublications & Productsplus iconPatient and Public MaterialsFact SheetsGuidelinesplus iconControl & EliminationDrug-Resistant TBInfection Control & PreventionLaboratory & GenotypingTB & HIVTB in Specific PopulationsTesting & DiagnosisTreatmentVaccines & ImmunizationsArchived TB GuidelinesGuides & Toolkitsplus iconAggregate ReportsCDC TB Surveillance TrainingCore CurriculumEffective TB Interviewing for Contact InvestigationEthnographic GuidesFalse-Positive Investigation ToolkitForging Partnerships to Eliminate TuberculosisGuide to Application of GenotypingLTBI: A Guide for Primary Health Care ProvidersMantoux Tuberculin Skin Testing ProductsReport of Verified Case of Tuberculosis (RVCT)Self-Study ModulesTB Contact Investigation Interviewing Skills CourseTB eDOT ToolkitUnderstanding the TB Cohort Review ProcessNewslettersplus iconTB Notes, No. 4, 2023TB Notes, No. 3, 2023TB Notes. No. 2, 2023TB Notes. No. 1, 2023TB Notes, No. 4, 2022TB Notes, No. 3, 2022TB Notes, No. 2, 2022TB Notes, No. 1, 2022TB Notes, No. 4, 2021TB Notes, No. 3, 2021TB Notes, No. 2, 2021TB Notes, No. 1, 2021Pamphlets, Brochures, Bookletsplus iconQuestions and AnswersPatient Education SeriesTuberculosis - Get the FactsTuberculosis - The Connection between TB and HIV12-Dose Regimen for Latent TB Infection-Patient Education BrochurePostersplus iconMantoux Tuberculin Skin Test Wall ChartWorld TB DayThink TBStop TBTake on TBReports & Articlesplus iconDTBE Authored Journal ArticlesTuberculosis Laboratory Aggregate ReportsSlide Setsplus iconIntroduction to TuberculosisEpidemiology of Tuberculosis Among Non-U.S.​–Born Persons in the United States, 1993–2016Self-Study Modules on Tuberculosis, 1-5 Slide SetsThe Tuberculosis (TB) in Correctional Settingsplus iconFacilitator GuideIntroduction to TB GenotypingEpidemiology of Tuberculosis in Correctional Facilities, United States, 1993-2017Prevention and Control of Tuberculosis in Correctional and Detention FacilitiesGuidelines for Preventing the Transmission of M. TB in Health care SettingsInvestigation of Contacts of Persons with Infectious TBEpidemiology of Pediatric Tuberculosis in the United StatesTargeted Tuberculosis Testing and Treatment of Latent Tuberculosis InfectionElectronic Tools & ResourcesWeb-Based Courses & Webinarsplus iconTB 101 for Health Care WorkersContent SyndicationInfographicsplus iconSocial Media GraphicsCustomizable Take on TB Infographic with InstructionsEventsWorld TB Dayplus iconU.S. TB ChampionsHistoryFeaturesplus iconTB Risk FactorsTreating Latent TB Infection with Short-Course RegimensWorld Tuberculosis (TB) Day 2021World Tuberculosis (TB) Day 2020Linksplus iconState TB Control OfficesAbout Usplus iconMission Statement and Activitiesplus iconDTBE Strategic PlanNational TB Program ObjectivesOrganization ChartAdvisory Groupsplus iconFederal TB Task Force To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue